BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15968252)

  • 1. Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association?
    Marrache F; Cazals-Hatem D; Kianmanesh R; Palazzo L; Couvelard A; O'Toole D; Maire F; Hammel P; Levy P; Sauvanet A; Ruszniewski P
    Pancreas; 2005 Jul; 31(1):79-83. PubMed ID: 15968252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine neoplasm.
    Goh BK; Ooi LL; Kumarasinghe MP; Tan YM; Cheow PC; Chow PK; Chung YF; Wong WK
    Pancreatology; 2006; 6(6):520-6. PubMed ID: 17124434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature review.
    Kadota Y; Shinoda M; Tanabe M; Tsujikawa H; Ueno A; Masugi Y; Oshima G; Nishiyama R; Tanaka M; Mihara K; Abe Y; Yagi H; Kitago M; Itano O; Kawachi S; Aiura K; Tanimoto A; Sakamaoto M; Kitagawa Y
    World J Surg Oncol; 2013 Mar; 11():75. PubMed ID: 23517520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Neuroendocrine Tumors and Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review.
    Manuel-Vazquez A; Ramia JM; Latorre-Fragua R; Valle-Rubio A; Arteaga-Peralta V; Ramiro-Pérez C; de la Plaza-Llamas R
    Pancreas; 2018; 47(5):551-555. PubMed ID: 29683974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
    J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms.
    Penheiter AR; Deelchand DK; Kittelson E; Damgard SE; Murphy SJ; O'Brien DR; Bamlet WR; Passow MR; Smyrk TC; Couch FJ; Vasmatzis G; Port JD; Marjańska M; Carlson SK
    Pancreatology; 2018 Jan; 18(1):46-53. PubMed ID: 29170050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
    Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
    Adsay NV; Conlon KC; Zee SY; Brennan MF; Klimstra DS
    Cancer; 2002 Jan; 94(1):62-77. PubMed ID: 11815961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
    Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
    Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
    Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
    JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
    Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Precursors of Pancreatic cancer: Intraepithelial Neoplasia (PanIN) and Intraductal Papillary Mucinous Neoplasms (IPMN)].
    Ledniczky G; Bognár G; Bereczky B; Barabás L; Ondrejka P
    Magy Seb; 2009 Feb; 62(1):22-6. PubMed ID: 19218165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine cells in intraductal papillary-mucinous neoplasms of the pancreas. A histochemical and immunohistochemical study.
    Terada T; Ohta T; Kitamura Y; Ashida K; Matsunaga Y; Kato M
    Virchows Arch; 1997 Jul; 431(1):31-6. PubMed ID: 9247630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.